Ammassari, Adriana <br/><br/>
Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  12 2018 
 - 481-490 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1944-7884 
<br/><br/><label>Standard No.: </label>10.1097/QAI.0000000000001834  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Retroviral Agents--therapeutic use<br/>Antiretroviral Therapy, Highly Active--methods<br/>HIV Infections--drug therapy<br/>Humans<br/>Treatment Failure<br/>Assessment of Medication Adherence